Wassmer, Evangeline
Birmingham Women's Hospital
9 papers on CoChatORCID 0000-0002-2446-1106
Most cited papers
- Verified
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., et al. (2013) · Multiple Sclerosis Journal
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 1,130
- Verified
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics
RNA regulation and diseaseinterferon and immune responses
Cited by 923
- Verified
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
Hacohen, Y., Absoud, M., Deiva, K., Hemingway, C., Nytrova, P., Woodhall, M., Palace, J., Wassmer, E., Tardieu, M., Vincent, A., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 230
- Verified
Diagnostic algorithm for relapsing acquired demyelinating syndromes in children
Hacohen, Y., Mankad, K., Chong, W. K., Barkhof, F., Vincent, A., Lim, M., Wassmer, E., Ciccarelli, O., & Hemingway, C. (2017) · Neurology
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 190
- Verified
Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial
O'Callaghan, F. J. K., Edwards, S. W., Alber, F. D., Cortina Borja, M., Hancock, E., Johnson, A. L., Kennedy, C. R., Likeman, M., Lux, A. L., Mackay, M. T., et al. (2018) · The Lancet Child & Adolescent Health
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 167
- Verified
De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures
Ito, Y., Carss, K. J., Duarte, S. T., Hartley, T., Keren, B., Kurian, M. A., Marey, I., Charles, P., Mendonça, C., Nava, C., et al. (2018) · The American Journal of Human Genetics
Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases
Cited by 41
- Verified
Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria
Sedani, S., Lim, M., Hemingway, C., Wassmer, E., & Absoud, M. (2012) · Multiple Sclerosis Journal
Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills
Cited by 28
- Verified
Expanding the genetic and phenotypic spectrum of branched‐chain amino acid transferase 2 deficiency
Knerr, I., Colombo, R., Urquhart, J., Morais, A., Merinero, B., Oyarzabal, A., Pérez, B., Jones, S. A., Perveen, R., Preece, M. A., et al. (2019) · Journal of Inherited Metabolic Disease
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 25
- Verified
Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders
Sanchis-Juan, A., Megy, K., Stephens, J., Armirola Ricaurte, C., Dewhurst, E., Low, K., French, C. E., Grozeva, D., Stirrups, K., Erwood, M., et al. (2023) · The American Journal of Human Genetics
Genomics and Rare DiseasesGenomic variations and chromosomal abnormalities
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free